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Abstract
Hexylresorcinol has been demonstrated to induce chromosome aberrations in eukaryotic cells at
doses  of  0.5,  0.05,  and  0.005  mg/g  body  weight.  The  metabolic  transformation  of
hexylresorcinol in mice decreases its genotoxic effect. The mutagenic effect is retained for three
days only after the administration of the highest dose of hexylresorcinol (0.5 mg/g); during the
first two days, lower doses are also genotoxic. Therefore, hexylresorcinol doses lower than 0.5
mg/g body weight are metabolized within two days to the extent precluding the expression of
the  cytotoxic  effect.  After  a  single  administration  to  mice,  exogenous  hexylresorcinol  is
transformed at a rate of 0.0025-0.025 mg/day. © 2005 Pleiades Publishing, Inc.
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